Lecture 11: COPD Flashcards

1
Q

COPD definition

A

Collection of conditions characterized by persistent expiratory airflow limitation that is not fully reversible associated w/ enhanced inflammatory response and exacerbations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Big FEV1 / FVC difference between COPD and asthma

A

Ratio cannot NORMALIZE even after administration of bronchodilator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chronic bronchitis definition

A

Chronic, productive cough on most days for at least 3 months a year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Chronic bronchitis pathology

A

Hypertrophy/hyperplasia of mucus glands, bronchial wall inflammation/fibrosis –> bronchial wall thickening (edema, BM thickening, increased SM) with decreased luminal size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Chronic bronchitis is a _________ dx; emphysema is a _________ dx

A

Clinical; pathological

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe emphysema

A

Destruction of lung parenchyma and enlargement of air spaces distal to terminal bronchiole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Types of emphysema and description

A

Centrilobular (proximal acinar): predominantly involves respiraotry bronchiole and upper lungs, smokers; Panlobular (panacinar), lower lungs, see in alpha1-antitrypsin deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does alpha-1 antitrypsin do?

A

Inhibitor of neutrophil elastase, which is a proteolytic enzyme that degrades elastin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does smoking involve the protease-antiprotease theory?

A

Inactivates alpha-1 antitrypsin and recruits neutrophils

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Variants in alpha-1 antitrypsin disease and which is more dangerous and which is more common

A

Z-variant (more dangerous) and S-variant (more common)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Z-variant

A

Failure to form alpha-1 antitrypsin salt bridge leading to slowly folding protein that form globules that are never secreted and accumulate hepatocytes (cirrhosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

S-variant

A

Renders alpha-1 antitrypsin more susceptible to proteolysis; not associated with intracellular accumulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Emphysema: lung compliance increased or decreased

A

Increased!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the equal pressure point?

A

Point at which the pressure within the bronchus and within the chest cavity are equal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Why is there decreased trans pulmonary pressure in emphysema?

A

Because the lungs are more compliant (less stiff), they cannot withstand a strong pressure differential

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why does a decreased trans pulmonary pressure impact emphysema?

A

You reach the EPP earlier, meaning that on expiration, there is obstruction

17
Q

What does decreased airway tethering mean?

A

Fewer “tethers” of the airways mean they cannot be open fully (decreased diameter)

18
Q

FRC and TLC in ephysema. What about VC?

A

FRC is larger because of increased compliance, TLC is increased (hyperinflation); VC is reduced

19
Q

Mechanical disadvantage in ephysema

A

Enlarged lungs –> flattened diaphragm –> less strength of diaphragm (dyspnea)

20
Q

Describe dynamic hyperinflation in a patient with COPD during exercise

A

They struggle with breathing out, meaning less time to breath out, so their end expiratory lung volume INCREASES as minute vent increases

21
Q

V/Q in chronic bronchitis

A

Problem with airway leads to V/Q mismatch

22
Q

V/Q in emphysema

A

Destroyed whole unit (alveolus and capillary), so may not get hypoxemia

23
Q

Alveolar hypoventilation in emphysema

A

Increased work of breathing –> decreased central ventilatory drive AND increased dead space due to tissue destruction (this area is ventilated but not perfused = V/Q mismatch)

24
Q

Symptoms of COPD

A

Dyspnea, cough (w/ sputum), exacerbations

25
Q

What precipitates an exacerbation?

A

Viral infections, pollution, bronchospasm

26
Q

Exam findings with emphysema

A

Prolonged expiratory phase, decreased breath sounds, wheezing (expiratory), ronchi

27
Q

Exam findings with severe emphysema/COPD

A

Barrel-shaped chest, purse-lipped breathing (increases pressure in airways to stent open airways), emaciation

28
Q

How can you see emphysema on X-ray/CT?

A

Hyperinflation by counting ribs and “moth eaten” appearance on CT

29
Q

Causes of pulmonary HT in COPD

A

Hypoxia and other vessel changes, thromboembolism, parenchymal destruction (decreased vessels), LV dysfunction, hyperinflation

30
Q

Chronic bronchitis and smoking (3 histological changes)

A

Mucus hypertrophy and hyperplasia, broncial wall inflammation, impaired mucociliary clearance

31
Q

Chronic emphysema and smoking (2 histological changes)

A

Increased number of neutrophils –> increased elastase, oxidation of alpha-1 antitrypsin –> decreased function

32
Q

What are other risk factors for emphysema?

A

Occupational exposures and indoor air pollution (cooking with biomass fuels)

33
Q

Blue bloater

A

Chronic bronchitis: overweight, cyanotic, elevated Hb, peripheral edema, ronchi and wheezing

34
Q

Pink puffer

A

Emphysema: older and thin, severe dyspnea, quiet chest, xray: hyperinflation with flattened diaphragm

35
Q

What is the diagnostic requirement for COPD?

A

Airflow obstruction: you can have ephysema and chronic bronchitis without COPD

36
Q

How is COPD a systemic disease?

A

SYSTEMIC inflammation related to ischemic HD, osteoporosis, metabolic syndrome, depression via systemic inflammation

37
Q

Emphysema tx

A

Proven survival benefit: smoking cessation and supplemental O2 for hypoxemic pts

38
Q

Emphysema sx management

A

Inhaled bronchodilators and corticosteroids

39
Q

Describe lung volume reduction surgery

A

Reduces lung volume to reduce physiologic dead-space, increases elastic recoil, improve mechanic functioning of diaphragm